Open AccessP102 (0151) DURABLE REMISSION FOR TWO PATIENTS WITH EARLY RELAPSE OF HODGKIN LYMPHOMA, TREATED WITH BRENTUXIMAB VEDOTIN PLUS GEMCITABINE, WITHOUT AUTOLOGOUS STEM CELL TRANSPLANTATION: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Publication year - 2018
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000547946.29769.67
Subject(s) - brentuximab vedotin , medicine , oncology , autologous stem cell transplantation , gemcitabine , stem cell , transplantation , lymphoma , chemotherapy , hodgkin lymphoma , biology , genetics